🔗 Visit the ClinicalTrials.gov page for NCT00381797
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Lack of efficacy of bevacizumab plus irinotecan in children with recurrent malignant glioma and diffuse brainstem glioma: a Pediatric Brain Tumor Consortium study. | J Clin Oncol | 2010 | 1.50 |
| 2 | The rationale for targeted therapies in medulloblastoma. | Neuro Oncol | 2013 | 0.92 |
| 3 | Targeted brain tumor treatment-current perspectives. | Drug Target Insights | 2007 | 0.83 |
| 4 | Bevacizumab dosing strategy in paediatric cancer patients based on population pharmacokinetic analysis with external validation. | Br J Clin Pharmacol | 2015 | 0.81 |
| 5 | Bevacizumab-associated osteonecrosis of the wrist and knee in three pediatric patients with recurrent CNS tumors. | J Clin Oncol | 2012 | 0.78 |
| 6 | Immune-based therapeutics for pediatric cancer. | Expert Opin Biol Ther | 2010 | 0.78 |
| 7 | Advances in paediatric cancer treatment. | Transl Pediatr | 2014 | 0.76 |